Previous studies of alum-adjuvanted killed SARS-CoV vaccines sometimes described eosinophilic infiltration into the lungs after challenge, suggestive of immunopathological disease (Bolles . However, we could find no evidence of an eosinophilic infiltration into the lungs of either young or aged mice after i.n. or s.c. VRP-SARS-N immunization and challenge, when compared to mice vaccinated with a control VRP (Figures 1D and S6 ). 


Section:vrp-sars-n immunization does not result in increased eosinophil infiltration into the lungs